OTC Medicine Topical (cream / gel / ointment) • Vasodilator; hair growth stimulant
✓ Medically Reviewed Monograph

Minoxidil

Also known as / Synonyms: Minoxidil, Rogaine, Topical K-ATP Opener

Vasodilator and hair growth stimulant applied to the scalp twice daily to stop hair loss and stimulate new hair regrowth.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Minoxidil
Active Ingredient: Minoxidil
Dosage Form: Topical (cream / gel / ointment)
Available Strengths: 2%, 5%, 10% topical solution/foam; 2.5 mg, 5 mg oral tablets
Prescription Status: Both Rx and OTC strengths exist (verified)
Approved Routes:
Topical Oral
Popular Verified Brands:
Tugain Rogaine Morr Mintop Regaine (India)
Regulatory Standards: Approved by CDSCO; OTC for 2% and 5% topical solutions; Schedule H prescription for oral formulations in India. US FDA approved for androgenetic alopecia.
🎯

Approved Indications & Medical Uses

  • Treatment of androgenetic alopecia (male and female pattern baldness) of the crown and vertex of the scalp.
  • Stabilization and stimulation of hair regrowth in chronic telogen effluvium and traction alopecia.
  • Off-label: oral low-dose minoxidil (1.25 to 5 mg/day) for resistant diffuse hair thinning.
  • Severe refractory hypertension (oral high-dose, combined with a diuretic and beta-blocker).
🚫

Contraindications (Do Not Use If…)

  • Known hypersensitivity to minoxidil, propylene glycol, or formulation components.
  • Pheochromocytoma (oral minoxidil stimulates catecholamine release).
  • Scalp conditions with broken, inflamed, infected, or irritated skin (increases systemic absorption).
🛡️

Important Clinical Precautions & Warnings

  • Initial hair shedding phase: a temporary increase in hair shedding frequently occurs during the first 2 to 6 weeks of treatment; this represents anagen induction as old telogen hairs are shed.
  • Continuous use required: hair regrowth benefits peak at 4 to 12 months; discontinuation results in progressive loss of regrown hair within 3 to 6 months.
  • Systemic absorption and cardiovascular effects: tachycardia, fluid retention, peripheral edema, and orthostatic dizziness can occur if applied to damaged scalp or swallowed.
  • Unwanted facial hypertrichosis: avoid dripping solution onto the forehead, face, or neck; wash hands thoroughly after application.
  • Avoid contact with eyes: flushes thoroughly with cool water if accidental ocular contact occurs.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Safety and efficacy have not been established in patients under 18 years. Geriatric: Effectiveness may be reduced in older individuals with longstanding atrophic hair follicles.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Scalp irritation, pruritus, dry scalp, dandruff, localized contact dermatitis, initial hair shedding, and hypertrichosis (unwanted hair growth).

🚨 Serious Side Effects — Seek Urgent Medical Care

Severe contact allergic dermatitis, significant fluid retention and congestive heart failure exacerbation (systemic), reflex tachycardia, pericardial effusion (rare with oral), and severe hypotension.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Topical retinoids (tretinoin): co-application increases stratum corneum permeability and significantly increases systemic minoxidil absorption.
  • Guanethidine: oral minoxidil potentiates profound orthostatic hypotension.
  • Systemic vasodilators and antihypertensives: additive hypotensive response with oral minoxidil.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Topical and oral minoxidil are contraindicated during pregnancy. Rare cases of hypertrichosis and neonatal anomalies have been reported following maternal exposure. Discontinue immediately upon pregnancy confirmation.

Lactation & Breastfeeding:

Use with caution — see notes

Minoxidil is excreted in human breast milk following systemic exposure. Due to potential cardiovascular side effects in the infant, avoid use while breastfeeding unless clearly evaluated by a physician.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store topical solution and foam at 20°C to 25°C (68°F to 77°F). Foam is pressurized; keep away from open flame or excessive heat.

⏱️ Missed Dose Protocol:

Apply the regular 1 mL dose as soon as remembered. If close to the next application, skip and resume morning/evening routine. Do not apply double amounts.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Minoxidil →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Minoxidil Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/minoxidil/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.